The global injection pen market was valued at USD 37.80 Billion in 2024 driven by the rising prevalence of chronic diseases and growing demand for self-administration devices across the globe. It is expected to grow at a CAGR of 7.20% during the forecast period of 2025-2034 and attain a market value of USD 75.76 Billion by 2034.
Base Year
Historical Year
Forecast Year
The market is propelled by the increasing demand for self-administration devices, advancements in smart injection technologies, and growing patient preference for convenient and precise drug delivery systems. These trends are enhancing market adoption across therapeutic areas like diabetes, osteoporosis, and growth hormone therapy.
In February 2023, Glooko partnered with Sanofi to integrate the SoloSmart device with its platform, enhancing diabetes management through improved insulin tracking. Such collaborations are expected to boost market growth in the forecast period.
North America is expected to lead the market, driven by advanced healthcare systems, high adoption rates of self-administration devices, and the strong presence of key players. The region continues to innovate, contributing to global market dynamics.
Injection pens are innovative medical devices designed for precise, user-friendly drug administration, widely used for conditions like diabetes, osteoporosis, and growth hormone deficiencies. The market is driven by the rising prevalence of chronic diseases and the growing demand for self-administration solutions. Key trends include advancements in smart pens and strategic collaborations. These factors, coupled with increased patient convenience are propelling the growth and adoption of injection pens globally.
Rising Prevalence of Chronic Disease Drives Market Growth
The rising prevalence of chronic disease significantly boosts the demand for injection pens. It offers an easy-to-use, patient-friendly solution, allowing for self-administration and improved adherence to treatment regimens. According to the World Health Organization 2023 data, non-communicable or chronic diseases were responsible for approximately 41 million deaths annually, accounting for 74% of all global fatalities. As conditions like diabetes, and rheumatoid arthritis become more common, patients require consistent and convenient administration of biologics and insulin therapies.
Several trends and developments are being observed in the market to enhance the current situation. The following are some of the noteworthy trends.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Therapy
Market Breakup by End User
Market Breakup by Region
Market Share by Type to Witness Significant Growth
Based on the type, the market is divided into disposable and re-usable. Among these, disposable is expected to lead the market during the forecast period, owing to a rise in the adoption of disposable injection pens across the globe. In addition, there is a focus on preventing the risk of cross-contamination and needle stick injuries associated with reusable injection pens. As healthcare professionals and patients prioritize safety, the demand for disposable type is likely to rise steadily in the forecast period.
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. Among these, North America is expected to dominate the market due to the presence of robust healthcare infrastructure and the prominent key players in the region. Companies like Novo Nordisk and Sanofi are heavily investing in research and development to come up with innovative products.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Established in 1849, Pfizer is headquartered in New York, USA. The company has developed the Genotropin Pen, an advanced injection pen for administering human growth hormone therapy. The pen simplifies dosage adjustments and ensures precise delivery, offering convenience and improved treatment adherence for patients requiring growth hormone replacement therapy.
Founded in 1996 and headquartered in Basel, Switzerland, Novartis developed the Revolizer, a reusable injection pen system designed for delivering respiratory drugs. This innovative device enhances dose accuracy and patient convenience, supporting its commitment to improving drug delivery solutions across multiple therapeutic areas.
Founded in 1923, Novo Nordisk A/S is headquartered in Denmark. The company is renowned for its FlexTouch and FlexPen insulin pens, which are widely used for diabetes management. These pens ensure accurate insulin delivery, ease of use, and enhanced patient compliance, establishing Novo Nordisk as a leader in the market.
Established in 1973, Sanofi SA is headquartered in Paris, France. The company has developed the SoloStar insulin injection pen, a widely used device for managing diabetes. The pen is designed for precision, convenience, and ease of use, helping patients maintain effective glucose control and improving their overall diabetes management experience.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Becton, Dickinson and Company, Eli Lilly and Company, Ypsomed AG, Biocon Biologics Limited, Owen Mumford Ltd., and Merck KGaA.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Therapy |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share